
    
      On Day 1, eligible subjects will receive a single 20 mL dose of bupivacaine hydrochloride
      (HCl) 0.5% with epinephrine 1:200,000 within 2 hours prior to the surgical procedure as an
      ultrasound-guided femoral nerve block (FNB). EXPAREL 266 mg expanded to 60 mL with
      preservative-free sterile normal saline will be infiltrated into the surgical site prior to
      wound closure. There will be no local coadministration of the two drugs.

      Blood samples for bupivacaine pharmacokinetic (PK) analysis will be obtained from subjects at
      baseline (prior to bupivacaine HCl administration for nerve block), 15 minutes, 30 minutes,
      and 1, 2, 4, 8, 12, 24, 48, 72, and 96 hours after the beginning of EXPAREL administration,
      and on Day 14.
    
  